mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0004 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0006 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0007 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
0.0007 |